MTOR and lymphangioleiomyomatosis: The pharmacological treatment of LAM primarily involves the use of mTOR inhibitors, specifically sirolimus or everolimus [21]; Due to the high cost and limited availability of mTOR inhibitors in Ethiopia, these medications were not prescribed for our patient.